Indian pharmaceutical companies have consistently upheld a commendable standing in the global pharmaceutical industry.
They have adeptly assumed leadership roles in the production of generic drugs, both within the domestic landscape and on the international stage.
India holds the third position globally in terms of pharmaceutical product production by volume, commanding a formidable 20% share in the global supply volume.
Sun Pharma, a stalwart in the pharmaceutical domain, stands as one of India’s largest and most entrenched pharmaceutical companies. Known for diverse portfolio and robust global presence.
Another giant in the Indian pharmaceutical sector, Dr. Reddy’s Laboratories, commands prominence with a robust product pipeline and a substantial footprint in both domestic and international markets.
Cipla, known for its expansive range of pharmaceutical products, has secured a formidable position across various therapeutic domains. Its burgeoning international presence is complemented by forays into new ventures.
Playing a pivotal role in the manufacturing of active pharmaceutical ingredients (APIs),Its significance in the API segment is underscored by substantial capital expenditure, amounting to 2,800 crore rupees at existing units.
Aurobindo Pharma, distinguished by its emphasis on research and development, boasts a diverse product portfolio and a pervasive presence in various global markets.